Table 2 Cox regression analysis for relapse (KEM cohort).

From: Validation analysis of the novel imaging-based prognostic radiomic signature in patients undergoing primary surgery for advanced high-grade serous ovarian cancer (HGSOC)

 

Univariate

Multivariable

Feature

HR (95% CI)

P value

HR (95% CI)

P value

RPV (low/med vs high)

1.94 (1.24–3.04)

0.00383

1.69 (1.06–2.71)

0.0279

FIGO stagea

2.14 (1.59–2.87)

4.18 × 10−7

1.8 (1.32–2.45)

0.000191

Residual disease (none vs any)

3.55 (2.54–4.96)

1.22 × 10−13

3.00 (2.09–4.32)

3.16 × 10−9

Age (<60 y vs >60 y)

1.32 (0.964–1.81)

0.0837

0.88 (0.62–1.24)

0.463

ECOGa

1.75 (1.12–2.74)

0.0147

1.18 (0.722–1.94)

0.506

  1. aAs continuous variable.
  2. Bold values indicate statistical significance.
Back to article page